ArticlePharmaceuticals (Basel, Switzerland)2024

Adverse Reactions to Evolocumab: Analysis of Real-World Data from EudraVigilance.

Fabrizio Calapai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.